Prevention of Sudden Death: Selection of Patients at Risk

  • Jeffrey S. Borer
  • David Miller
  • Paul Phillips
  • Jeffrey W. Moses
  • Harvey Goldberg
  • Jeffrey Fisher
Part of the Ettore Majorana International Science Series book series (SIPC)


Prevention of sudden death requires identification of patients at risk, elucidation of the pathophysiology of the lethal event, and definition of appropriate therapy. As yet, achievement of these three goals is incomplete. Patients generally do not undergo currently available testing procedures (which are at best not totally predictive) until potential risk is heralded by some clinical event. Thus, patients with clinically silent or asymptomatic electrical instability or with coronary artery/ischemic heart disease without angina pectoris may not enter the health care system before an episode of sudden death. Moreover, even if descriptors of risk are noted prospectively, the pathophysiology of sudden lethal events is incompletely understood. The nature and clinical importance of subcellular biochemical abnormalities leading to cardiac electrical instability largely are unknown, and the relationship between chronic, irreversible electrical instability and active ischemia in patients with coronary artery disease remains unclear. Finally, even when risk and likely mechanism of death both are identified in an individual patient, current pharmacological and surgical therapies offer incomplete protection against the lethal event.


Ejection Fraction Sudden Death Additional Prognostic Information Electrical Instability Stable Ischemic Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. H. Miller and J. S. Borer, Exercise testing early after myocardial infarction: Risks and benefits, Amer. J. Med. 72: 427–438 (1982).CrossRefGoogle Scholar
  2. 2.
    P. Theroux, D. D. Waters, C. Halphen, J. C. Debaisieux and H. F. Mizgala, Prognostic value of exercise testing soon after myocardial infarction, New Engl. J. Med. 301:341–345 (1979).Google Scholar
  3. 3.
    M. Ericsson, A. Granath, P. Ohlsen, T. Sodermark and U. Volpe, Arrhythmias and symptoms during treadmill testing three weeks after myocardial infarction in 100 patients, Brit. Heart J. 35:787–790 (1973).CrossRefGoogle Scholar
  4. 4.
    J. W. Smith, C. A. Dennis, A. Gassmann, J. A. Gaines, M. Staman, B. Phibbs and F. I. Marcus, Exercise testing three weeks after myocardial infarction, Chest 75:12–16 (1979).CrossRefGoogle Scholar
  5. 5.
    R. A. Shulze, Jr., H. W. Strauss and B. Pitt, Sudden death in the year following myocardial infarction: Relation to ventricular premature contractions in the late hospital phase and left ventricular ejection fraction, Amer. J. Med. 62:192–199 (1977).CrossRefGoogle Scholar
  6. 6.
    M. Sami, H. Kramer and R. F. DeBusk, The prognostic significance of serial exercise testing after myocardial infarction, Circulation 60:1238–1246 (1979).Google Scholar
  7. 7.
    M. R. Starling, M. H. Crawford, G. T. Kennedy and R. A. O’Rourke, Exercise testing early after myocardial infarction Predictive value for subsequent unstable angina and death, Amer. J. Cardiol. 46:909–914 (1980).CrossRefGoogle Scholar
  8. 8.
    K. J. Silverman, L. C. Becker, B. H. Bulkley et al., Value of early thallium - 201 scintigrapht for predicting mortality in patients with acute myocardial infarction, Circulation 61:996–1003 (1980).Google Scholar
  9. 9.
    L. C. Becker, The early post infaction patient: Identification and aggressive intervention in high risk groups; Abstract, Proceedings of Conference on Sudden Coronary Death, New York Academy of Sciences, New York, p. 33 (1981).Google Scholar
  10. 10.
    A. Battler, R. Slutsky, J. Karliner, V. Froelicher, W. Ashburn and J. Ross, Jr., Left ventricular ejection fraction and first third ejection fraction early after acute myocardial infarction: Value for predicting mortality and morbidity, Amer. J. Cardiol. 45:197–202 (1980).CrossRefGoogle Scholar
  11. 11.
    R. Shulze, J. Rouleau, P. Rigo, S. Bowers, H. W. Strauss, P,H,B, Ventricular arrhythmias in the late hospital phase of acute myocardial infarction, Circulation 52:1006–11 (1975).Google Scholar
  12. 12.
    J. S. Borer, D. R. Rosing, R. H. Miller et al., Natural history of left ventricular function during one year after acute myocardial infarction: Comparison with clinical, electrocardiographic and biochemical determination, Amer. J. Cardiol. 46: 1–12 (1980).CrossRefGoogle Scholar
  13. 13.
    D. H. Miller, J. S. Borer, P. D. Kligfield, D. L. Hayes and E. Whitacre, Independence of exercise-induced electrocardiographic ischemia and left ventricular function in patients with recent myocardial infarction, Clin. Research 30 (in press) (1982).Google Scholar
  14. 14.
    J. S. Borer, K. Kent, S. L. Bacharach et al., Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease, Circulation 60:572–580 (1979).Google Scholar
  15. 15.
    P. Phillips, J. S. Borer, J. Jacobstein, K. Plaucher, J. Carter, J. Moses, J. Goldstein, M. Collins and J. Fisher, Prognostically critical coronary stenoses: Identification by radionuclide cineangiography, Amer. J. Cardiol. 49:991 (1982).CrossRefGoogle Scholar
  16. 16.
    R. F. DeBusk, D. M. Davidson, N. Houston and J. Fitzgerald, Serial ambulatory electrocardiography and treadmill exercise testing after uncomplicated myocardial infarction, Amer. J. Cardiol. 45:547–554 (1980).CrossRefGoogle Scholar
  17. 17.
    J. B. Uther, D. V. Cody, A. R. Denniss, D. A. Richards, P. A. Russell and A. A. Young, Ventricular programmed stimulation and exercise ST segment depression as predictors of post infarction mortality, Amer. J. Cardiol. 49:902 (1982).CrossRefGoogle Scholar
  18. 18.
    C. Friedman, J. Moses, J. S. Borer, H. G. Goldberg, D. H. Miller and J. Fisher, Prognostic value of programmed ventricular stimulation early after infarction in high risk patients, Circulation (submitted).Google Scholar
  19. 19.
    Norwegian Multicenter Study Group, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, New Engl. J. Med. 304:801–807 (1981).CrossRefGoogle Scholar
  20. 20.
    J. S. Borer, S. L. Bacharach, M. V. Green, K. M. Kent, S. E. Epstein and G. S. Johnston, Real-time radionuclide cineangiography in the non-invasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary artery disease, New Engl. J. Med. 297:839–844 (1977).Google Scholar
  21. 21.
    J. S. Borer, S. L. Bacharach, M. V. Green, K. M. Kent, G. S. Johnston and S. E. Epstein, Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease: Assessment by radionuclide cineangiography in symptomatic and asymptomatic patients, Circulation 57:314–320 (1978).Google Scholar
  22. 22.
    C. Hochreiter, J. S. Borer, P. Kligfield, R. Devereux, J. Jacobstein and M. Kase, Complex ventricular arrhythmias in patients with valvular regurgitation: A potentially important, clinically overlooked phenomenon?, Amer. J. Cardiol. 49:910 (1982).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Jeffrey S. Borer
    • 1
  • David Miller
    • 1
  • Paul Phillips
    • 1
  • Jeffrey W. Moses
    • 1
  • Harvey Goldberg
    • 1
    • 2
  • Jeffrey Fisher
    • 1
  1. 1.Cardiology DivisionNew York Hospital - Cornell Medical CenterNew YorkUSA
  2. 2.Isadore Rosenfeld Heart Foundation Fellow of the Cornell University Medical CollegeUSA

Personalised recommendations